Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.